Trump administration pauses new hospice and home health providers’ enrollment in Medicare
Trump administration halts new hospice and home health providers’ enrollment in Medicare
Trump administration pauses new hospice and home – The Centers for Medicare and Medicaid Services (CMS) has taken a decisive step by implementing a six-month pause on the enrollment of new hospice and home health care providers into the Medicare program. This action, announced Wednesday, marks the latest initiative by the Trump administration to address what it claims is a pervasive issue of fraudulent activities within the healthcare sector. The decision aims to curb the entry of unscrupulous entities while the agency intensifies its investigations into existing providers suspected of exploiting the system.
Combating Fraud Through Regulatory Measures
CMS Administrator Dr. Mehmet Oz emphasized the urgency of the situation in a statement, highlighting the systemic nature of fraud in the hospice and home health care spaces. According to Oz, these fraudulent practices have targeted the most vulnerable Medicare beneficiaries, siphoning funds from American taxpayers. The moratorium is part of a broader strategy to “block new bad actors from accessing Medicare while we work to uncover and eliminate those already taking advantage of the system,” he stated.
“We’ve seen systemic and deeply troubling fraud in the hospice and home health space, with bad actors exploiting some of our most vulnerable Medicare patients and stealing money from the American taxpayer,” said CMS Administrator Dr. Mehmet Oz.
Oz has been collaborating closely with Vice President JD Vance’s Anti-Fraud Task Force, which has been a central component of the administration’s efforts to tighten oversight in healthcare. The task force’s work has led to targeted actions across multiple states, with Vance set to unveil further fraud-related developments during a press briefing later that day. Additionally, the vice president is scheduled to visit Maine on Thursday to address the state’s role in the administration’s anti-fraud campaign, which has drawn scrutiny for its Medicaid programs.
Focus on Maine and Other High-Risk States
Maine has become a focal point of the administration’s fraud crackdown, with President Donald Trump previously labeling the state a “hotbed of fraud” during his February State of the Union address. The state’s Senate race, where GOP Senator Susan Collins is vying for a sixth term, is anticipated to be one of the most competitive battlegrounds in the upcoming November midterm elections. This political context may amplify the pressure on state officials to demonstrate accountability for their Medicaid-funded programs.
As part of its strategy, CMS has already suspended $70 million in payments to 773 hospice facilities and 23 home health agencies in Los Angeles, citing suspicions of fraudulent behavior. The agency has also taken steps to revoke or deactivate hundreds of similar providers in other regions, including Arizona, California, Georgia, Nevada, and Texas, as part of its expanded review process. These measures have increased scrutiny of new entrants in the hospice sector and heightened oversight of claims submitted by home health agencies in Florida, Illinois, Oklahoma, and North Carolina.
Broader Implications of the Moratorium
While the move is framed as a necessary step to prevent fraud, critics argue it may inadvertently restrict access to care for patients who rely on these services. The National Alliance for Care at Home, a prominent advocacy group, has raised concerns about the potential impact of the enrollment freeze on legitimate providers. In a statement, the alliance warned that the moratorium could create significant barriers for healthcare organizations operating within areas of high demand or limited capacity, particularly in rural and underserved communities.
“An enrollment moratorium raises serious access-to-care concerns in areas where patient demand is growing or existing capacity is already strained, leading to longer wait times, reduced service availability, and fewer choices for patients,” the alliance said. The group has worked with CMS to submit recommendations aimed at identifying fraudulent actors without imposing excessive burdens on providers acting in good faith. This collaboration is seen as a critical component of the administration’s efforts to balance enforcement with the need to maintain healthcare accessibility.
Additional Measures Targeting Durable Medical Equipment
Alongside the hospice and home health enrollment pause, CMS has also imposed a similar six-month moratorium on certain companies that supply durable medical equipment (DME), such as wheelchairs, hospital beds, and oxygen devices. The agency claims this industry is similarly plagued by widespread fraud, with providers allegedly overcharging or providing substandard services to Medicare beneficiaries. These actions underscore the administration’s commitment to addressing systemic issues across multiple healthcare sectors.
Oz has been proactive in communicating with state governors, sending letters and recording videos to demand improved oversight of Medicaid programs. In February, he specifically addressed Maine Governor Janet Mills, a Democrat, regarding concerns about the state’s treatment of Medicaid-funded autism care. The letter highlighted discrepancies in the program and called for transparency in identifying and recovering funds misused by fraudulent actors. Mills described the effort as a “political attack,” suggesting the initiative may be more about exerting pressure on states than addressing genuine financial irregularities.
Expanding Oversight and Investigations
Recent months have seen CMS intensify its investigative efforts, conducting site visits to hospice facilities and scrutinizing claims from home health agencies. The agency has also increased oversight in key states, including Arizona, California, Georgia, Nevada, and Texas, where it has identified patterns of improper activity. These actions are part of a coordinated approach to root out fraud and ensure that Medicare dollars are spent efficiently and effectively.
President Trump has consistently championed these measures, framing them as essential to protecting taxpayer funds. His administration’s focus on fraud has led to a series of policy changes, including the suspension of payments to Minnesota’s Medicaid program earlier this year. This trend reflects a broader strategy to hold providers accountable for financial misconduct, even as it raises questions about the potential consequences for legitimate healthcare organizations.
While the CMS actions have been praised by some as a necessary intervention, others have criticized the approach as overly broad. The National Alliance for Care at Home and similar organizations argue that the moratorium could disrupt care for patients who depend on hospice services, especially in regions where staffing shortages or high patient demand have already created challenges. They advocate for a more nuanced approach that distinguishes between fraudulent providers and those who operate with integrity.
Oz’s efforts have been complemented by the Anti-Fraud Task Force, which has been tasked with identifying and eliminating bad actors across the healthcare landscape. The task force’s work has included targeted investigations in specific states, such as Maine, and has contributed to the administration’s narrative of widespread fraud. However, the effectiveness of these measures remains a subject of debate, with critics questioning whether the focus on certain states and industries is based on concrete evidence or political motivations.
As the administration continues to push for stricter enforcement, the implications for the healthcare sector are significant. The moratorium on new enrollments could lead to a reduction in the number of providers offering hospice and home health care, potentially limiting patient options. At the same time, the focus on durable medical equipment companies highlights the administration’s determination to address fraud in multiple domains. The balance between preventing financial abuse and maintaining access to care will be central to the success of these initiatives.
